How is your third treatment different from your previous regimens?
It's completely understandable to feel apprehensive about adding bevacizumab (Avastin) to your carboplatin and Taxol regimen. This combination is commonly used for recurrent ovarian cancer, especially when the cancer has returned after previous platinum-based Show Full Answer
How is your third treatment different from your previous regimens?
It's completely understandable to feel apprehensive about adding bevacizumab (Avastin) to your carboplatin and Taxol regimen. This combination is commonly used for recurrent ovarian cancer, especially when the cancer has returned after previous platinum-based treatments.
The main difference is that bevacizumab is a targeted therapy drug that works differently than chemotherapy. It seeks out and kills cancer cells more specifically, rather than affecting all rapidly dividing cells like traditional chemo does.
Since you've already experienced carboplatin and Taxol twice before, you know what to expect from those drugs. The bevacizumab adds another layer of treatment that may help improve outcomes, particularly if your cancer responded well initially but has returned.
What you might expect:
While you're familiar with the side effects of carboplatin and Taxol (like hair loss, nausea, and bone pain), bevacizumab can bring its own side effects to watch for:
- High blood pressure
- Fatigue
- Bleeding or bruising more easily
- Wound healing issues
Many members on MyOvarianCancerTeam have shared their experiences with various treatment combinations. One member described going through a research process and getting multiple opinions before settling on a regimen that combined a treatment from their first round with a new class of medications—ultimately achieving stable disease.
Your care team should monitor you closely, especially for blood pressure changes. Don't hesitate to communicate any concerns or side effects you experience.
November 9, 2025
Join
Your Privacy Choices
